Top Markets
Coin of the day
Intellipharmaceutics International Inc. Intellipharmaceutics International Inc.

Intellipharmaceutics International Inc.

IPCI
Peringkat dalam Saham #37499
Intellipharmaceutics International Inc., founded in Toronto, Canada, in 1998,... Intellipharmaceutics International Inc., founded in Toronto, Canada, in 1998, is a pharmaceutical company that focuses on the research, development, and manufacturing of innovative and generic controlled-release and targeted-release oral solid dosage medications, primarily for the United States market. The company leverages its patented Hypermatrix technology to create advanced drug delivery systems, an array of product candidates, and a robust pipeline across diverse therapeutic areas, including neurological, cardiovascular, gastrointestinal, diabetes, and pain management conditions. Its current product portfolio includes extended-release formulations like Focalin XR for hyperactivity disorder, Keppra XR for partial onset seizures, Effexor XR to treat depression, and Protonix for gastroesophageal reflux disease. Other offerings feature Glucophage XR for type 2 diabetes, Seroquel XR for schizophrenia and mood disorders, Lamictal XR for epilepsy, Pristiq for depression, Coreg CR for heart failure and hypertension, and Ranexa for chronic angina. Furthermore, Intellipharmaceutics is actively developing additional controlled-release drugs such as OxyContin for pain relief and Regabatin XR for neuropathic pain management. The company operates under a license and commercialization agreement with Par Pharmaceutical Inc.
Harga Saham
$0.05897422
Terakhir disinkronkan: 2024-04-02
Kapitalisasi Pasar
$1.64M
Perubahan (1 hari)
0.07%
Perubahan (1 tahun)
-60.68%
Negara
CA
Perdagangan Intellipharmaceutics International Inc. (IPCI)

Kategori

EPS untuk Intellipharmaceutics International Inc. (IPCI)
EPS per August 2023 TTM: $-0.10
Menurut laporan keuangan terbaru dan harga saham Intellipharmaceutics International Inc., EPS perusahaan saat ini (TTM) adalah $-0.10. Pada akhir 2021, perusahaan memiliki EPS sebesar $-0.10 penurunan dibandingkan dengan EPS tahun 2020 sebesar $-0.22.
Riwayat EPS untuk Intellipharmaceutics International Inc. dari 1999 hingga 2026
EPS di akhir setiap tahun
Tahun EPS Mengubah
2026 (TTM) $-0.10 6.44%
2022 $-0.09 -11.09%
2021 $-0.10 -55.32%
2020 $-0.22 37.50%
2019 $-0.16 -94.44%
2018 $-2.88 0.00%
2017 $-2.88 -24.21%
2016 $-3.80 21.41%
2015 $-3.13 87.43%
2014 $-1.67 -71.40%
2013 $-5.84 64.04%
2012 $-3.56 9.54%
2011 $-3.25 -38.45%
2010 $-5.28 -8.65%
2008 $-5.78 -60.38%
2007 $-14.59 -77.93%
2006 $-66.11 -34.18%
2005 $-100.44 9.95%
2004 $-91.35 128.38%
2003 $-40.00 55.16%
2002 $-25.78 26.50%
2001 $-20.38 37.24%
2000 $-14.85 -19.64%
1999 $-18.48 0.00%
EPS untuk perusahaan sejenis atau pesaing
Perusahaan EPS Perbedaan EPS Negara
$17.32 -18,179.33%
US
$-7.98 8,229.85%
US
$-5.29 5,421.92%
AU
$27.74 -29,056.16%
NL
- -
CH